UNJHAFORPharmaceuticals
Unjha Formulations Ltd — Cash Flow Statement
₹20.29
-1.10%
Unjha Formulations Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -0.23 Cr | 0.92 Cr | -0.36 Cr | 0.37 Cr | — |
| Capital Expenditure | -0.18 Cr | -0.11 Cr | -0.10 Cr | -0.02 Cr | — |
| End Cash Position | 0.64 Cr | 0.87 Cr | 0.01 Cr | 0.43 Cr | — |
| Beginning Cash Position | 0.87 Cr | 0.01 Cr | 0.43 Cr | 0.17 Cr | — |
| Changes In Cash | -0.23 Cr | 0.86 Cr | -0.42 Cr | 0.26 Cr | — |
| Financing Cash Flow | -81000.00 | -0.05 Cr | -0.06 Cr | -0.13 Cr | — |
| Interest Paid Cff | -81000.00 | -0.05 Cr | -0.06 Cr | -0.13 Cr | — |
| Net Issuance Payments Of Debt | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Short Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Long Term Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investing Cash Flow | -0.18 Cr | -0.11 Cr | -0.10 Cr | -44000.00 | — |
| Interest Received Cfi | 0.00 | 0.00 | 21000.00 | 0.02 Cr | — |
| Dividends Received Cfi | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of Investment | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Business Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of Business | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Intangibles Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of Intangibles | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -0.18 Cr | -0.11 Cr | -0.10 Cr | -0.02 Cr | — |
| Sale Of PPE | 30000.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of PPE | -0.18 Cr | -0.11 Cr | -0.10 Cr | -0.02 Cr | — |
| Capital Expenditure Reported | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Operating Cash Flow | -0.04 Cr | 1.03 Cr | -0.26 Cr | 0.39 Cr | — |
| Taxes Refund Paid | -0.14 Cr | -0.05 Cr | -0.05 Cr | -0.05 Cr | — |
| Change In Working Capital | -0.50 Cr | 0.49 Cr | -0.67 Cr | -0.05 Cr | — |
| Change In Other Current Liabilities | 0.07 Cr | 0.02 Cr | -0.02 Cr | 57000.00 | — |
| Change In Other Current Assets | -0.06 Cr | 0.00 | 0.07 Cr | -0.07 Cr | — |
| Change In Payable | -0.88 Cr | 1.10 Cr | -0.31 Cr | -0.35 Cr | — |
| Change In Inventory | 0.23 Cr | -0.12 Cr | -0.07 Cr | 0.08 Cr | — |
| Change In Receivables | 0.13 Cr | -0.51 Cr | -0.28 Cr | 0.28 Cr | — |
| Other Non Cash Items | 81000.00 | 0.05 Cr | 0.06 Cr | 0.12 Cr | — |
| Depreciation And Amortization | 0.10 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr | — |
| Amortization Cash Flow | 0.00 | 0.00 | 0.00 | — | — |
| Depreciation | 0.10 Cr | 0.08 Cr | 0.08 Cr | 0.08 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -0.03 Cr | 38000.00 | 0.00 | 0.00 | — |
| Gain Loss On Sale Of PPE | -17000.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | 0.52 Cr | 0.45 Cr | 0.33 Cr | 0.30 Cr | — |
| Provisionand Write Offof Assets | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Paid Cfo | — | — | — | -0.13 Cr | -0.17 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Unjha Formulations Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.